SetPoint Medical Appoints Terry Bevirt as VP of Clinical Affairs

LG Thin-Clients Feature Built-in RFID Capabilities Optimized for Use in Healthcare Facilities

Supporting its mission to help healthcare providers streamline operations and deliver exceptional patient care, LG Business Solutions USA introduced a new LG thin client...

Experien Group Acquired by Veranex

Veranex combines product development, regulatory, and market access expertise — globally and across complex and emerging markets.

SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Terry Bevirt as Vice President of Clinical Affairs. Ms. Bevirt brings more than 20 years of leadership experience in clinical research operations for pharmaceutical and biotechnology companies that range from large multinationals to startups.

At SetPoint, Ms. Bevirt will oversee clinical programs as the company advances its bioelectronic medicine approach for inflammatory diseases including rheumatoid arthritis and Crohn’s disease. She will report to Anthony Arnold, Chief Executive Officer of SetPoint Medical.

Anthony Arnold, Chief Executive Officer of SetPoint Medical, “SetPoint is pleased to welcome Terry, whose senior leadership expertise and successful history running pivotal clinical trials will be crucial to us as we conduct clinical trials with our new proprietary bioelectronic medicine device.”  Arnold added, “Terry will work closely with our new Chief Medical Officer and other team leaders that make up a capable clinical team and ideally position SetPoint to develop and execute our clinical strategy through commercialization.”

SetPoint is developing a novel proprietary bioelectronic medicine platform to treat a variety of inflammation-mediated autoimmune diseases, using an implanted device to stimulate the vagus nerve, activating the body’s natural Inflammatory Reflex to produce a systemic anti-inflammatory effect. The emerging field of bioelectronic medicine aims to address unmet patient needs by delivering digital doses to modulate physiological circuits to treat diseases historically treated with drugs in a more targeted fashion.

Prior to joining SetPoint, Ms. Bevirt was Senior Director, Head of Clinical Operations at Armagen, where she managed operational strategy, study design feasibility, and the successful execution of clinical trials. Prior, she served as Therapeutic Area Planning and Operations Director at Amgen, where she provided strategic leadership and direction for study operations staff of 25, and she earlier held several other key clinical positions. Prior to Amgen, she held positions with Pharmacia, Affiliated Research Centers and Abbott Laboratories. She holds a B.S. in Medical Technology from the University of Wisconsin at Milwaukee and is a Certified Clinical Research Associate.



Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

At Advanced Clinical, and from previous organizations, Belgrave serves as a mentor to several colleagues, where he challenges them to think outside of the box and take risks.

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.